Response assessment criteria and their applications in Lymphoma

Part 2

Mateen C. Moghbel, Erik Mittra, Andrea Gallamini, Ryan Niederkohr, Delphine L. Chen, Katherine Zukotynski, Helen Nadel, Lale Kostakoglu

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Interim and end-of-Treatment PET/CT have become central to the evaluation of Hodgkin and non-Hodgkin lymphoma. This review article seeks to aid clinical decision making by providing an overview of available data on the diagnostic and prognostic value of PET/CT imaging for response assessment and pretransplant evaluation in lymphoma. The relative strengths and limitations of these techniques in various disease subtypes and clinical scenarios are explored, along with their current standards for reporting and latest developments. Particular attention is given to response-Adapted therapy, which is emerging as a cornerstone of clinical management.

Original languageEnglish (US)
Pages (from-to)13-22
Number of pages10
JournalJournal of Nuclear Medicine
Volume58
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Lymphoma
Hodgkin Disease
Non-Hodgkin's Lymphoma
Therapeutics
Clinical Decision-Making

Keywords

  • Lymphoma
  • PET/CT response assessment
  • Responseadapted therapy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Moghbel, M. C., Mittra, E., Gallamini, A., Niederkohr, R., Chen, D. L., Zukotynski, K., ... Kostakoglu, L. (2017). Response assessment criteria and their applications in Lymphoma: Part 2. Journal of Nuclear Medicine, 58(1), 13-22. https://doi.org/10.2967/jnumed.116.184242

Response assessment criteria and their applications in Lymphoma : Part 2. / Moghbel, Mateen C.; Mittra, Erik; Gallamini, Andrea; Niederkohr, Ryan; Chen, Delphine L.; Zukotynski, Katherine; Nadel, Helen; Kostakoglu, Lale.

In: Journal of Nuclear Medicine, Vol. 58, No. 1, 01.01.2017, p. 13-22.

Research output: Contribution to journalArticle

Moghbel, MC, Mittra, E, Gallamini, A, Niederkohr, R, Chen, DL, Zukotynski, K, Nadel, H & Kostakoglu, L 2017, 'Response assessment criteria and their applications in Lymphoma: Part 2', Journal of Nuclear Medicine, vol. 58, no. 1, pp. 13-22. https://doi.org/10.2967/jnumed.116.184242
Moghbel, Mateen C. ; Mittra, Erik ; Gallamini, Andrea ; Niederkohr, Ryan ; Chen, Delphine L. ; Zukotynski, Katherine ; Nadel, Helen ; Kostakoglu, Lale. / Response assessment criteria and their applications in Lymphoma : Part 2. In: Journal of Nuclear Medicine. 2017 ; Vol. 58, No. 1. pp. 13-22.
@article{51e0d006fa8a408082d194d4d2691d9a,
title = "Response assessment criteria and their applications in Lymphoma: Part 2",
abstract = "Interim and end-of-Treatment PET/CT have become central to the evaluation of Hodgkin and non-Hodgkin lymphoma. This review article seeks to aid clinical decision making by providing an overview of available data on the diagnostic and prognostic value of PET/CT imaging for response assessment and pretransplant evaluation in lymphoma. The relative strengths and limitations of these techniques in various disease subtypes and clinical scenarios are explored, along with their current standards for reporting and latest developments. Particular attention is given to response-Adapted therapy, which is emerging as a cornerstone of clinical management.",
keywords = "Lymphoma, PET/CT response assessment, Responseadapted therapy",
author = "Moghbel, {Mateen C.} and Erik Mittra and Andrea Gallamini and Ryan Niederkohr and Chen, {Delphine L.} and Katherine Zukotynski and Helen Nadel and Lale Kostakoglu",
year = "2017",
month = "1",
day = "1",
doi = "10.2967/jnumed.116.184242",
language = "English (US)",
volume = "58",
pages = "13--22",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "1",

}

TY - JOUR

T1 - Response assessment criteria and their applications in Lymphoma

T2 - Part 2

AU - Moghbel, Mateen C.

AU - Mittra, Erik

AU - Gallamini, Andrea

AU - Niederkohr, Ryan

AU - Chen, Delphine L.

AU - Zukotynski, Katherine

AU - Nadel, Helen

AU - Kostakoglu, Lale

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Interim and end-of-Treatment PET/CT have become central to the evaluation of Hodgkin and non-Hodgkin lymphoma. This review article seeks to aid clinical decision making by providing an overview of available data on the diagnostic and prognostic value of PET/CT imaging for response assessment and pretransplant evaluation in lymphoma. The relative strengths and limitations of these techniques in various disease subtypes and clinical scenarios are explored, along with their current standards for reporting and latest developments. Particular attention is given to response-Adapted therapy, which is emerging as a cornerstone of clinical management.

AB - Interim and end-of-Treatment PET/CT have become central to the evaluation of Hodgkin and non-Hodgkin lymphoma. This review article seeks to aid clinical decision making by providing an overview of available data on the diagnostic and prognostic value of PET/CT imaging for response assessment and pretransplant evaluation in lymphoma. The relative strengths and limitations of these techniques in various disease subtypes and clinical scenarios are explored, along with their current standards for reporting and latest developments. Particular attention is given to response-Adapted therapy, which is emerging as a cornerstone of clinical management.

KW - Lymphoma

KW - PET/CT response assessment

KW - Responseadapted therapy

UR - http://www.scopus.com/inward/record.url?scp=85009113882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009113882&partnerID=8YFLogxK

U2 - 10.2967/jnumed.116.184242

DO - 10.2967/jnumed.116.184242

M3 - Article

VL - 58

SP - 13

EP - 22

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 1

ER -